[Physiopathological bases for the treatment of acute alcoholic hepatitis].
Parés
A
A
Unidad de Hepatología, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, IDIBAPS, Barcelona, España. pares@medicina.ub.es
Caballería
J
J
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000437:Alcoholism / Q000150:complications; D045930:Anabolic Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D019587:Dietary Supplements; D004750:Enteral Nutrition; D005260:Female; D006519:Hepatitis, Alcoholic / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D000069285:Infliximab; D016031:Liver Transplantation; D008297:Male; D044342:Malnutrition / Q000150:complications; D010431:Pentoxifylline / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis; D013695:Temperance
D000305:Adrenal Cortex Hormones; D045930:Anabolic Agents; D000911:Antibodies, Monoclonal; D000975:Antioxidants; D000069285:Infliximab; D010431:Pentoxifylline